{
  "created_at": "Wed Jul 14 2:59:50 +0000 2021",
  "id_str": "1414882556567334915",
  "full_text": "The agreement for 20m doses of Covaxin was signed by Brazil’s health ministry in February for a price 50% higher than was offered three months earlier by the jab’s developer, Bharat Biotech. Both companies deny any wrongdoing https://t.co/QEq2wrnhuN",
  "display_text_range": [
    0,
    249
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/QEq2wrnhuN",
        "expanded_url": "https://econ.st/3dWLB4n",
        "display_url": "econ.st/3dWLB4n",
        "indices": [
          226,
          249
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 35,
  "favorite_count": 81,
  "possibly_sensitive": false,
  "original_created_at": "Tue Jul 13 09:41:03 +0000 2021"
}